Targeted delivery of lidocaine and other local anesthetics and a method for treatment of cough, asthma and tussive attacks
US7998463B2 · kind B2 · utility
3Cited by
0References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 10, 2008 |
| Grant date | Aug 16, 2011 |
| Priority date | — |
| Expiry date | Sep 16, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/008
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An anti-tussive nebulized solution for targeted delivery of lidocaine into conducting and central airways. A method for treatment of cough and tussive attacks or episodes using said lidocaine solution. A nebulized lidocaine solution administered in daily dose from about 10 mg to 80 mg of lidocaine dissolved in a saline and nebulized into an aerosol having a mass median aerodynamic diameter 3 μm to 10 μm and a geometric standard deviation less than 1.7 using an electronic nebulizer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.